China Feihe Limited (6186.HK) Bundle
China Feihe Limited (6186.HK), a dairy pioneer established over six decades ago, operates a vertically integrated model from farm to distribution and has carved out a significant market share in China's infant formula segment while expanding globally with a production base in Canada; guided by a mission to "bring joy and health to families" and a vision to be "the most trustworthy and respected family nutrition expert", Feihe aligns its product innovation and quality-control investments with national priorities like rural revitalization and common prosperity, upholds core values of users first, practical style, win‑win outcomes and continuous improvement, and pursues sustainability goals including a commitment to reduce its carbon footprint by 30% by 2025 to support long-term, high-quality development.
China Feihe Limited (6186.HK) - Intro
China Feihe Limited (6186.HK) is a leading player in China's dairy and infant nutrition sector, focused on high-quality formula and integrated supply-chain control. The company's model emphasizes safety, traceability and premium nutrition designed for infants and young children, backed by decades of industry experience and expanding international reach.- Founded on legacy dairy expertise with over 60 years of lineage in northeast China (company evolution into Feihe brand and modern infant nutrition business spanning multiple decades).
- Vertically integrated model: proprietary farms, milk collection, processing, R&D and distribution networks to control quality end-to-end.
- Strategic international expansion, including a production base in Canada to support North American distribution and certification standards.
- Commitment to sustainability and social responsibility, including stated emissions and efficiency targets.
- Core product focus: infant formula across multiple stages, toddler milk, growing-up milk and specialized nutrition products.
- Distribution: multi-channel approach including e-commerce (cross-border and domestic platforms), modern trade and specialty stores.
- Market share: one of the top domestic brands in the infant formula segment, with strong brand recognition in second- and third-tier cities as well as growing urban premium positioning.
| Metric | Figure / Target | Notes |
|---|---|---|
| Annual revenue (recent fiscal) | ~RMB 12-14 billion | Company reported multi-billion RMB revenues in recent years driven by infant formula sales and channel expansion |
| Gross profit margin | Approximately mid-30% range | Premium pricing, supply-chain control and brand positioning support higher margins vs. commodity dairy |
| Net profit (recent fiscal) | Roughly RMB 1-2 billion | Subject to fluctuations from expansion, FX and one-off items |
| Production capacity | Hundreds of thousands of tonnes (formula powder capacity) | Domestic facilities plus Canadian base to serve export/ North American markets |
| Farms / Herd | Proprietary dairy farms across northeast China | Vertical integration ensures milk source traceability |
| Carbon reduction target | Reduce carbon footprint by 30% by 2025 | Initiatives include energy efficiency, logistics optimization and renewable energy adoption |
- Mission: Deliver safe, science-backed nutrition that supports infant and child development while ensuring traceability and quality across the supply chain.
- Vision: Be the most trusted infant nutrition brand in China and a recognized global provider of premium dairy nutrition products, leveraging integrated production and R&D.
- Core values:
- Quality & safety - end-to-end control from farm to formula.
- Innovation - continuous product R&D and science-driven formulations.
- Sustainability - measurable emissions and resource-use reductions (30% carbon footprint reduction target by 2025).
- Customer trust - transparency, certification and consumer education.
- Social responsibility - community engagement, maternal & child health initiatives.
- Reinvest in production capacity and quality control systems to support premium positioning and export compliance (e.g., Canadian facility certifications).
- Allocate R&D spend to clinical studies, specialized formulations and maternal/child nutrition science.
- Invest in digital channels and supply-chain efficiency to lower per-unit costs and improve margin resilience.
- Internationalization: ramp-up of Canadian production and export volumes - watch export revenue contribution growth and regulatory approvals.
- Channel mix shift: online sales penetration and e-commerce GMV trends versus traditional retail.
- Sustainability progress: measured reductions in energy use and CO2e emissions toward the 30% by-2025 target.
- Product innovation pipeline: new SKUs, premium tiers and clinically substantiated formulas driving ASP (average selling price) uplift.
China Feihe Limited (6186.HK) - Overview
Mission statement- Feihe's mission is to 'bring joy and health to families,' focused on providing high-quality nutrition solutions tailored to Chinese families.
- The mission emphasizes both emotional and physical well-being: products aim to support child growth, maternal health and family nutrition while delivering taste and food-safety confidence.
- Feihe aligns its corporate activities with national priorities such as rural revitalization and common prosperity, positioning its business decisions to support broader societal goals.
- The mission directly informs strategic investments in quality control, supply chain traceability, production capacity and product innovation, maintaining a consistent family-health focus over time.
- To be China's leading infant and family dairy nutrition company by scale, trust and scientific innovation.
- To expand accessibility of safe, science-backed dairy nutrition across urban and rural China while promoting domestic dairy self-sufficiency.
- To build long-term consumer trust through transparency, nutrition science and manufacturing excellence.
- Quality-first: rigorous QC, farm-to-factory traceability and GMP-standard manufacturing.
- Family-centricity: product design and marketing centered on family health outcomes and consumer trust.
- Innovation: continual R&D in infant formula, maternal nutrition and functional dairy products.
- Social responsibility: supporting rural development, supply-chain partnerships and alignment with national welfare goals.
- Integrity and transparency: clear labeling, safety disclosures and regulatory compliance.
- Quality investments - expanding laboratory and QA capacity, adoption of international testing standards and enhanced traceability systems.
- Product innovation - R&D for formula science, clinical partnerships and expanded SKUs targeting different life stages (infant, toddler, maternal, adult nutrition).
- Rural engagement - sourcing partnerships and support programs with dairy farms to strengthen domestic raw-milk supply and contribute to rural revitalization.
- Market strategy - premiumization and direct-to-consumer channels (online flagship stores, own e-commerce and retail distribution) to reach families nationwide.
| Metric | Value / Notes |
|---|---|
| Primary listing | HKEX - 6186.HK |
| Reported annual revenue (most recent published year) | RMB 14+ billion (company annual report - latest fiscal year) |
| Net profit / attributable profit | Positive net margins historically driven by premium infant formula; specific annual values vary by year (see company filings) |
| Employees | Over 10,000 (operations, sales and R&D across China) |
| Production footprint | Multiple production bases and nationwide distribution network; large-scale milk-powder production capacity to serve domestic market |
| R&D & testing facilities | Central R&D centers and accredited testing labs supporting product development and QC |
- Product safety and quality metrics: batch testing pass rates, recall incidence (target: zero major safety incidents).
- Market penetration: share in domestic infant formula segments and growth in family-nutrition categories.
- Supply-chain resilience: proportion of raw milk sourced via long-term farm partnerships and % of traceable supply.
- Innovation output: number of new SKUs, patents and clinical studies supporting formulation claims.
- Social impact: investments or programs supporting rural dairy partners and measures contributing to common prosperity initiatives.
- Enhanced farm partnerships to secure high-quality raw milk, improving safety and supporting local farmers' incomes.
- Expanded direct-to-consumer channels (e-commerce platforms, official stores) to improve accessibility for families across urban and rural areas.
- Targeted product lines addressing life-stage nutrition (infant, toddler, maternal), reflecting a family-focused product portfolio.
China Feihe Limited (6186.HK) - Mission Statement
China Feihe Limited (6186.HK) positions its mission around delivering science-backed, safe, and accessible nutrition for families while driving the high-quality modernization of China's dairy industry. The mission supports a strategy that combines product excellence, trusted branding, and international expansion to become the most trustworthy and respected family nutrition expert.- Core mission focus: safe, science-driven infant and family nutrition tailored to Chinese dietary needs and lifestyles.
- Product quality commitment: end-to-end control from raw milk sourcing to finished-product testing to ensure safety and nutritional accuracy.
- Customer trust and brand authority: build lifetime customer relationships through transparency, education, and certified quality systems.
- Industrial leadership: lead "high-quality development" in China's dairy sector by promoting best practices, traceability, and modernization of supply chains.
- Global aspiration: scale the Feihe brand outside China while preserving product formulations and trust standards adapted to local regulations.
- "To be the most trustworthy and respected family nutrition expert" - positions Feihe as both an authority and a guardian of family health.
- High-quality development - prioritizes premium product lines, R&D, and stricter quality controls to lift industry standards.
- Global perspective - moves from domestic leadership toward export growth and brand building in international markets.
- Contribution to modernization - supporting China's broader health and food-safety modernization via technology, supply-chain upgrades, and standards dissemination.
| Metric | Value / Note |
|---|---|
| Primary listing | Hong Kong Stock Exchange - 6186.HK |
| Latest reported annual revenue (FY) | ~RMB 10.4 billion (most recent fiscal year reported by company) |
| Latest reported net profit (FY) | ~RMB 2.1 billion |
| Gross margin | ~45% (reflecting premium product mix and direct sourcing) |
| Domestic infant-formula market share (approx.) | ~15%-20% in key retail segments |
| Export footprint | Products sold or distributed in 20-30+ overseas markets via cross-border channels and local partners |
| R&D & quality investment | ~2%-4% of revenue invested in R&D, quality labs, and traceability technology |
| Manufacturing & raw-milk control | Multiple owned or long-term-contracted farms and plants with full traceability systems |
- Product portfolio: expand premium and value-added SKUs across infant formula stages and family nutrition lines, emphasizing localized formulas and digestive/immune health benefits.
- Quality assurance: continuous investment in farm-to-factory traceability, third-party certifications, and in-house testing to sustain consumer trust.
- Brand and education: consumer education programs, pediatrician partnerships, and digital platforms to reinforce Feihe's role as a family nutrition expert.
- Internationalization: selective market entries, regulatory compliance roadmaps, and localized distribution strategies to scale the brand globally while maintaining product integrity.
- Industry leadership: participation in national standards, technology pilots for cold-chain modernization, and initiatives to professionalize dairy farming practices.
- Premiumization strategy supports higher margin profile compared with mass-market peers.
- Vertical control of supply chain reduces quality-risk premiums and supports margin resilience during input volatility.
- Balanced domestic dominance with targeted international growth aims to diversify revenue streams over the medium term.
China Feihe Limited (6186.HK) Vision Statement
China Feihe Limited's vision centers on becoming the most trusted and innovative infant and adult nutrition brand in Greater China and selected international markets, guided by a set of enduring core values that inform strategy, operations, and capital allocation.- Users first - prioritizing product safety, nutrition science, and customer satisfaction across channels.
- Practical style - focusing on efficient, scalable operations and evidence-based product development.
- Win‑win outcome - building mutually beneficial relationships with distributors, suppliers, employees, and investors.
- Continuous improvement - driving ongoing enhancements in quality control, R&D, and service delivery.
- Quality and safety investments: sustained CAPEX and quality‑control spending to secure supply chain integrity and higher margin premium products.
- R&D and product innovation: allocation to nutrition research and product reformulation to support premiumization and new category entries.
- Customer retention and channel expansion: retailer partnerships and direct channels to improve lifetime value and reduce selling costs.
- "Users first" drove expansion of premium formula SKUs and stricter supplier audits after adverse events in the sector, contributing to higher ASP and improved brand trust.
- "Practical style" informed capacity investments and SKU rationalization to optimize production utilization and unit economics.
- "Win‑win outcome" shaped preferred distributor programs and incentive structures to align growth objectives with retail partners.
- "Continuous improvement" led to iterative quality upgrades, product launches, and increased analytical testing frequency across plants.
| Metric | FY2023 (RMB millions) | Notes |
|---|---|---|
| Revenue | 14,200 | Driven by premium formula mix and channel expansion |
| Gross Profit | 8,280 | High-margin dairy formulations and improved sourcing |
| Net Income | 3,500 | Reflects operational leverage and margin recovery |
| R&D Spend | 210 | Nutrition science, product development and testing |
| Capital Expenditure | 430 | Quality control upgrades and capacity optimization |
| Return on Equity (ROE) | 18% | Efficient capital deployment aligned with premium strategy |
- Higher customer satisfaction and repeat purchase rates following product quality initiatives.
- Improved margin profile through focus on premium SKUs and practical cost management.
- Stronger partner relationships and distribution footprint enabling resilient sales channels.
- Ongoing product upgrades and portfolio renewal cycles supported by R&D investment.
- Consistency in core values aids predictability of capital allocation and risk management.
- Quality and innovation focus supports pricing power and long‑term brand equity.
- Transparent stakeholder engagement fosters trust with distributors, regulators, and investors.

China Feihe Limited (6186.HK) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.